Breath test for monitoring blood sugar
Part of Hormones & metabolism clinical trials.
This study is testing a new device that measures blood sugar levels by analyzing your breath. It is for people with type 2 diabetes or those who are overweight, to see if the breath test can work as a non-invasive way to monitor glucose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes or you are overweight or obese (BMI ≥ 25).
- You are 18 years or older.
- You are able to sign a consent form.
- You are covered by French social security.
- You do not have a current respiratory infection.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if certain compounds in your breath can be linked to your blood sugar levels. It may help find new ways to monitor diabetes without finger pricks.
This trial tests a new breath-based sensor to detect low or high blood sugar (hypoglycemia or hyperglycemia) in people with type 1 or type 2 diabetes. It might offer a non-invasive way to monitor glucose levels.
This study uses a special machine to analyze exhaled breath to learn about different illnesses in children and teens. It may help researchers find breathing “signals” that reflect conditions like breathing problems, nervous system issues, or new/worsening type 1 diabetes.
This study looks at how your breath changes throughout the day in people with and without diabetes. Researchers want to find patterns in breath chemicals that could help understand diabetes better.
This study uses a simple breath test to predict gestational diabetes early in high-risk women. Researchers want to see if your breath can reveal signs of diabetes before symptoms appear, helping you get care sooner.
This study tests if a breath device can spot high or low blood sugar in teens with type 1 diabetes without a fingerstick. Participants will use the device a few times and share their CGM data.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.